Shedding light on immunotherapy for cancer.
Rosenberg
Steven A
SA
National Cancer Institute, Bethesda, Md, USA.
D000818:Animals; D019496:Cancer Vaccines; D004195:Disease Models, Animal; D007167:Immunotherapy / Q000379:methods; D016246:Lymphocytes, Tumor-Infiltrating; D008565:Membrane Proteins / Q000235:genetics / Q000276:immunology*; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000276:immunology*
D019496:Cancer Vaccines; D008565:Membrane Proteins; C505915:Tnfsf14 protein, mouse; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14; D014409:Tumor Necrosis Factor-alpha